Physician profile
Ross Morgan
NPI 1255881157
$3,540.50
in general payments reported to CMS, 2019-2025
13 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,080 · 2022: $922 · 2023: $207 · 2024: $219 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,050.30 | 2022-2025 | Apretude, Cabenuva, Dovato |
| Abbvie INC. | $986.84 | 2021-2025 | |
| Gilead Sciences, INC. | $936.43 | 2021-2025 | Biktarvy, Yeztugo |
| Novo Nordisk INC | $125.00 | 2022 | |
| Merck Sharp & Dohme LLC | $106.58 | 2021-2025 | Pifeltro |
| Axsome Therapeutics, INC. | $102.87 | 2025 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $100.12 | 2021 | |
| Antares Pharma, INC. | $37.05 | 2024 | Xyosted |
| Otsuka America Pharmaceutical, INC. | $25.69 | 2025 | Abilify Maintena, Abilify Asimtufii |
| Amneal Pharmaceuticals LLC | $21.56 | 2021 | |
| Organon LLC | $17.00 | 2024 | |
| Hologic Sales and Service, LLC | $15.74 | 2025 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.